- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06123910
Bovine Colostrum Supplementation in Athletes
Effect of Bovine Colostrum Supplementation on Neutrophil Function in Recreational Athletes
32 recreational athletes who will attend to the Grand Marathon in the nort west of Mexico, event that will be held on December 2, 2018 or 21k Trail to be held in April 2019 will be invited to the study. Participants will be informed about the study procedures through a consent informed. Participants will be randomly divided into two groups, 16 in the intervention group and 16 in the comparison group. The participants will be recreational athletes between 18 and 60 years old. They must have athletic experience of at least 3 years. The participants considered will be those who perform vigorous physical activity per week according to the criteria of the short version IPAQ instrument. Smoking subjects with food intolerances and allergies, cardiovascular history will be excluded. Patients who have had a respiratory infection symptom in the last two weeks will not be able to participate in the study. Participants who are consuming some type of food supplement will be excluded.
Two 18 ml of blood samples will be taken from the vein of the forearm by venipuncture of each participant, using K2EDTA tubes after and before supplementation period. Blood samples were taken before a corporal, aerobic and nutritional evaluations.
CB supplementation will begin 4 weeks prior to competition events. One group will consume 20 g of bovine colostrum daily in solution with water. The second group will consume a placebo product with a nutritional composition similar to the group with the treatment of bovine colostrum. Both groups should take the supplement before breakfast with empty stomach.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is widely accepted that exercise provide important health benefits. However, vigorous or extenuate exercise can affect the correct function of the immune system. Athletes who perform extreme physical routines to improve their athletic performance can develop opportunistic infections. After 3 to 72 h of physical activity there is a phase called "open window for infection", which predispose to upper track respiratory infection (UTRI). URTI is the main cause of medical consultation in athletes with vigorous exercise practices.
Neutrophils are one of the most abundant leucocytes in blood; their phagocytic activity is essential to control bacterial infections. Recently, the interest in knowing the participation of these cells in the sport field is growing. Neutrophilia refers to a high concentration of neutrophils in blood, and this is a common condition after exercise. The controversial part is that vigorous exercise could limit some important functions, such as oxidative burst, degranulation and phagocytosis until 6 h after exercise. However, there are contradictory results in this topic.
To alleviate those immunological alterations in athletes, a nutritional intervention should be included. Bovine colostrum has been evaluated as a supplement due to its potential immunomodulatory properties. It improves immunological parameters in individuals who achieve prolonged exercise sessions, allowing URTI reduction. Bovine colostrum is a yellow aqueous compound secreted by cow mammary glands the first 72 h after partum. Bovine colostrum contains anti-microbial peptides, enzymes, immunoglobulins, cytokines, microRNA and growth factors, which are able to modulate the immune system, at local (intestinal) and systemic level. Due to these characteristics, bovine colostrum has been used to improve the immune response under different physiological conditions.
A study showed that bovine colostrum supplementation induces a CD89 expression pre-exercise, after 5 weeks supplementation with 10 g of bovine colostrum. This result is important, since CD89 is a membrane receptor in neutrophils that recognize antibody/antigen complexes to prime phagocytosis and degranulation. In other study, 3 weeks of bovine colostrum supplementation improved neutrophil degranulation 1 h post-exercise in athletes, after 2 h of physical exercise. Authors evaluated neutrophil oxidative burst post-exercise after bovine colostrum supplementation, but no effects were observed. However, these authors found better oxidative burst after 4 weeks bovine colostrum supplementation. At this time, the effect of bovine colostrum in phagocytosis activity is unknown.
Concerning the effects of bovine colostrum supplementation in the URTI incidence, the results are contradictory. Although, others found no benefit in the incidence of URTI after a bovine colostrum supplementation, other studies showed promising results. A retrospective analysis conducted in 2003 showed a reduction of athletes with URTI in the bovine colostrum supplementation group. Likewise, another study reported less episodes and duration of infections in physically active subjects. Other studies described a tendency to decrease the incidence of URTI in swimmers and cyclists.
Study Design
A total of 28 athletes attending the "Hermosillo Grand Marathon" (December 2, 2018) and/or the "Hermosillo Half Marathon" (March 2019) will be part of this study. In this randomized clinical trial, study subjects will be randomly divided in two groups, 14 in the intervention group (bovine colostrum supplementation) and 14 in the comparison group (placebo supplementation). The participants will be recreational athletes between 18 and 60 years old. They must have athletic experience of at least 3 years and have to perform a vigorous physical activity per week according to the criteria of the short version IPAQ instrument. Smoking subjects, with food intolerances, allergies or cardiovascular history will not be included. Athletes with respiratory infection symptoms two weeks before beginning the supplementation won't be part of this protocol. Participants who are consuming some other type of food supplement will not be included. This protocol is currently under evaluation of the Ethics Committee of our institution. Participants will be informed about the study procedures and will sign an informed consent.
Bovine colostrum supplementation will begin 4 weeks prior to the competition event. The intervention group will consume 20 g of bovine colostrum, divided into two doses of 10 g/day. The first dose will be before breakfast and the second before lunch. The comparison group will consume a placebo product.
Two blood samples (24 ml of each one) will be taken from the vein of the forearm of each participant, using tubes with EDTA. The first sample will be taken before the competitive event after 10 min of a sitting rest. The second sample will be obtained immediately at the end of the test with 3 minutes of sitting rest.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sonora
-
Hermosillo, Sonora, Mexico, 83304
- Centro de Investigación en Alimentación y Desarrollo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- at least 3 years of training experience
- training for a half marathon competition
- No smokers
- Taking any kind of food supplements
- No alimentary allergies
Exclusion Criteria:
- Injuries
- not follow experimental indications
- cardiovascular disease
- treatment intolerances
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Colostrum bovine
Subjets taking a colostrum supplement
|
Colostrum bovine supplements, 25 kcal per portion, containing 0.25 g fats, 2.0 g CHO and 3 g protein.
Lactose reduced.
Other Names:
|
Placebo Comparator: Placebo
Subjets taking a commercial dairy product
|
Dairy comercial product.
25 kcal per portion, 1.3 g fats, 1.95 CHO and 1.3 protein.
Lactose based.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neutrophil phagocytic capacity
Time Frame: Before and after 4 weeks of supplementation
|
Percentage of phagocytic neutrophils
|
Before and after 4 weeks of supplementation
|
Monocytes phagocytic capacity
Time Frame: Before and after 4 weeks of supplementation
|
Percentage of phagocytic monocytes
|
Before and after 4 weeks of supplementation
|
neutrophils producing reactive oxygen species
Time Frame: before and after 4 weeks of supplementation
|
percentage of positive cells to fluorescence intensity by flow cytometry
|
before and after 4 weeks of supplementation
|
neutrophils reactive oxygen species production intensity
Time Frame: Before and after 4 weeks of supplementation
|
Mean intensity fluorescent by cells measured by flow cytometry
|
Before and after 4 weeks of supplementation
|
Monocytes producing reactive oxygen species
Time Frame: before and after 4 weeks of supplementation
|
percentage of positive cells to fluorescence intensity by flow cytometry
|
before and after 4 weeks of supplementation
|
Monocytes reactive oxygen species production intensity
Time Frame: Before and after 4 weeks of supplementation
|
Mean intensity fluorescent by cells measured by flow cytometry
|
Before and after 4 weeks of supplementation
|
VO2Max
Time Frame: Before and after 4 weeks of supplementation
|
Indicates participants aerobic condition (ml/kg/min)
|
Before and after 4 weeks of supplementation
|
Days presenting upper respiratory tract symptoms
Time Frame: During supplementation 4 weeks of supplementation
|
Total of days that participants refers any kind of upper respiratory symptoms
|
During supplementation 4 weeks of supplementation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: before and after 4 weeks of supplementation
|
Weight in kilograms
|
before and after 4 weeks of supplementation
|
Height
Time Frame: before and after 4 weeks of supplementation
|
Height in meters
|
before and after 4 weeks of supplementation
|
Body fat
Time Frame: before and after 4 weeks of supplementation
|
Body fat percentage
|
before and after 4 weeks of supplementation
|
Fat free mass
Time Frame: before and after 4 weeks of supplementation
|
fat free mass percentage
|
before and after 4 weeks of supplementation
|
Energy consumption
Time Frame: before, after 2 and 4 weeks of supplementation
|
Measure of regular calories consumption in kcal by 24 h records method
|
before, after 2 and 4 weeks of supplementation
|
Macronutrient consumption
Time Frame: before, after 2 weeks and 4 weeks of supplementation
|
Measure of regular consumption of carbohydrates in grams, Protein in grams, fats in grams by 24 h records method
|
before, after 2 weeks and 4 weeks of supplementation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jesús Hernández, PhD, Centro de Investigación en Alimentación y Desarrollo A.C.
Publications and helpful links
General Publications
- Hackney AC, Koltun KJ. The immune system and overtraining in athletes: clinical implications. Acta Clin Croat. 2012 Dec;51(4):633-41.
- Li TL, Gleeson M. The effect of single and repeated bouts of prolonged cycling on leukocyte redistribution, neutrophil degranulation, IL-6, and plasma stress hormone responses. Int J Sport Nutr Exerc Metab. 2004 Oct;14(5):501-16. doi: 10.1123/ijsnem.14.5.501.
- Peake J, Suzuki K. Neutrophil activation, antioxidant supplements and exercise-induced oxidative stress. Exerc Immunol Rev. 2004;10:129-41.
- Tritto ACC, Amano MT, De Cillo ME, Oliveira VA, Mendes SH, Yoshioka C, Roschel H, Camara NOS, Gualano B, Artioli GG. Effect of rapid weight loss and glutamine supplementation on immunosuppression of combat athletes: a double-blind, placebo-controlled study. J Exerc Rehabil. 2018 Feb 26;14(1):83-92. doi: 10.12965/jer.1835154.577. eCollection 2018 Feb.
- Bermon S, Castell LM, Calder PC, Bishop NC, Blomstrand E, Mooren FC, Kruger K, Kavazis AN, Quindry JC, Senchina DS, Nieman DC, Gleeson M, Pyne DB, Kitic CM, Close GL, Larson-Meyer DE, Marcos A, Meydani SN, Wu D, Walsh NP, Nagatomi R. Consensus Statement Immunonutrition and Exercise. Exerc Immunol Rev. 2017;23:8-50.
- Jones AW, Thatcher R, March DS, Davison G. Influence of 4 weeks of bovine colostrum supplementation on neutrophil and mucosal immune responses to prolonged cycling. Scand J Med Sci Sports. 2015 Dec;25(6):788-96. doi: 10.1111/sms.12433. Epub 2015 Feb 28.
- Shing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Stevenson L, Jenkins DG, Coombes JS. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol (1985). 2007 Mar;102(3):1113-22. doi: 10.1152/japplphysiol.00553.2006. Epub 2006 Nov 9.
- Rathe M, Muller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. 2014 Apr;72(4):237-54. doi: 10.1111/nure.12089. Epub 2014 Feb 26.
- Crooks CV, Wall CR, Cross ML, Rutherfurd-Markwick KJ. The effect of bovine colostrum supplementation on salivary IgA in distance runners. Int J Sport Nutr Exerc Metab. 2006 Feb;16(1):47-64. doi: 10.1123/ijsnem.16.1.47.
- Soligard T, Steffen K, Palmer D, Alonso JM, Bahr R, Lopes AD, Dvorak J, Grant ME, Meeuwisse W, Mountjoy M, Pena Costa LO, Salmina N, Budgett R, Engebretsen L. Sports injury and illness incidence in the Rio de Janeiro 2016 Olympic Summer Games: A prospective study of 11274 athletes from 207 countries. Br J Sports Med. 2017 Sep;51(17):1265-1271. doi: 10.1136/bjsports-2017-097956. Epub 2017 Jul 29.
- Palmer-Green D, Elliott N. Sports injury and illness epidemiology: Great Britain Olympic Team (TeamGB) surveillance during the Sochi 2014 Winter Olympic Games. Br J Sports Med. 2015 Jan;49(1):25-9. doi: 10.1136/bjsports-2014-094206. Epub 2014 Nov 25.
- McCarthy DA, Macdonald I, Grant M, Marbut M, Watling M, Nicholson S, Deeks JJ, Wade AJ, Perry JD. Studies on the immediate and delayed leucocytosis elicited by brief (30-min) strenuous exercise. Eur J Appl Physiol Occup Physiol. 1992;64(6):513-7. doi: 10.1007/BF00843760.
- Davison G, Diment BC. Bovine colostrum supplementation attenuates the decrease of salivary lysozyme and enhances the recovery of neutrophil function after prolonged exercise. Br J Nutr. 2010 May;103(10):1425-32. doi: 10.1017/S0007114509993503. Epub 2009 Dec 24.
- Pyne DB, Baker MS, Fricker PA, McDonald WA, Telford RD, Weidemann MJ. Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. Med Sci Sports Exerc. 1995 Apr;27(4):536-42.
- Robson PJ, Blannin AK, Walsh NP, Castell LM, Gleeson M. Effects of exercise intensity, duration and recovery on in vitro neutrophil function in male athletes. Int J Sports Med. 1999 Feb;20(2):128-35. doi: 10.1055/s-2007-971106.
- Santos VC, Levada-Pires AC, Alves SR, Pithon-Curi TC, Curi R, Cury-Boaventura MF. Changes in lymphocyte and neutrophil function induced by a marathon race. Cell Biochem Funct. 2013 Apr;31(3):237-43. doi: 10.1002/cbf.2877. Epub 2012 Sep 13.
- Brinkworth GD, Buckley JD. Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of upper respiratory tract infection in adult males. Eur J Nutr. 2003 Aug;42(4):228-32. doi: 10.1007/s00394-003-0410-x.
- Crooks C, Cross ML, Wall C, Ali A. Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers. Int J Sport Nutr Exerc Metab. 2010 Jun;20(3):224-35. doi: 10.1123/ijsnem.20.3.224.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- JHDEZ/CE/010-1/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Innate Immunity
-
Heinz Italia SpAFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoUnknown
-
Kırıkkale UniversityCompletedInnate Immunity | Periodontal Health
-
Bandim Health ProjectRadboud University Medical CenterCompletedInnate Immunity | Bacille Calmette-GuérinGuinea-Bissau
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Heinz Italia SpACompletedNutrition | Microbiota | Newborns | Innate ImmunityItaly
-
National Institute of Allergy and Infectious Diseases...CompletedInnate Immunity | HIV Negative | Adaptive ImmunityUnited States
-
Josefin EklöfNot yet recruitingCOPD | Trained Innate Immunity
-
Brugmann University HospitalCompleted
-
ATGen Canada IncTerminatedProstatic Neoplasm | Immunity, InnateCanada
-
ATGen Canada IncTerminatedColorectal Cancer | Immunity, InnateCanada
-
Institut Hospitalo-Universitaire Méditerranée InfectionAssistance Publique Hopitaux De Marseille; Institut Paoli-Calmettes; Hôpital... and other collaboratorsUnknownEndothelial Dysfunction | Sars-CoV2 | Immunization; Infection | Innate Immunity | Alveolar Lung DiseaseFrance
Clinical Trials on Colostrum bovine
-
National Nutrition and Food Technology InstituteCompletedCritical IllnessIran, Islamic Republic of
-
Ain Shams UniversityCompletedFeeding; Difficult, Newborn | Necrotizing Enterocolitis of Newborn | Late Onset Neonatal SepsisEgypt
-
Milky Way Life Sciences LLCBeth Israel Deaconess Medical CenterRecruitingCeliac Disease | Gluten Sensitivity | Non-celiac Gluten SensitivityUnited States
-
Assiut UniversityNot yet recruiting
-
Hadassah Medical OrganizationWithdrawnAsymptomatic Chronic HCV CarriersIsrael
-
National Nutrition and Food Technology InstituteCompletedCritical Illness | Multiple Organ Dysfunction Syndrome | Infection ComplicationIran, Islamic Republic of
-
University of MessinaUniversity of Victoria; University of AthensCompletedMenopause | Vulvovaginal Atrophy
-
H2O Health and Agriculture LLCUnknownPneumonia | DiarrheaGuatemala